Replies to post #1028 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

It is a very significant announcement, imo.

1) This board has long projected that BMS could be a partner, and now it's looking more likely.

2) The assumption is that VB-111 will be successful, in order for her to fulfill her "responsibilities in forming VBL's marketing strategy and commercialization plan for its Phase 3 candidate VB-111 and will work with VBL's leadership team to advance corporate strategy and U.S. activities".

All around very positive.